Needs in paediatric Rheumatology: The PRINTO perspective

Research output: Contribution to journalArticlepeer-review


Pediatric rheumatic diseases (PRD) encompass an heterogeneous group of rare diseases, ranging from juvenile idiopathic arthritis (JIA), juvenile systemic lupus erythematosus (JSLE) to juvenile dermatomyositis (JDM) and others. The PRD constitute a small market which is of little interest for pharmaceutical industries. Difficulties in operating in this specific area relate to problems which are peculiar to children, such as specific methods for the assessment of the primary outcome, or paediatric formulations, with the need of setting large networks in order to collect in a reasonable time frame an adequate number of patients.

Original languageEnglish
Pages (from-to)105-107
Number of pages3
JournalPharmaceuticals Policy and Law
Issue number1-2
Publication statusPublished - 2010


  • JDM
  • JIA
  • JSLE
  • Paediatric
  • rheumatic disease

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)


Dive into the research topics of 'Needs in paediatric Rheumatology: The PRINTO perspective'. Together they form a unique fingerprint.

Cite this